Project

Major adverse cardiovascular events in cancer patients during and after treatment with immune checkpoint inhibitors

Scheduled · 2024 until 2027

Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Scheduled
Start Date
2024
End Date
2027
Financing
KSSG, Others
Partner
Universitätsspital Basel (USB) Kantonsspital Baden (KSB)
Brief description/objective